Long-term therapy with recombinant human erythropoietin decreases percentage of CD152+ lymphocytes in primary glomerulonephritis haemodialysis patients

Nephrology Dialysis Transplantation

Volumn 17, Issue 6, 2002, Pages 1070-1080

  Trzonkowski, Piotr ^a   Myśliwska, Jolanta ^a   Dȩbska ślizień, Alicja ^a   Bryl, Ewa ^a,b   Rachoń, Dominik ^a   Myśliwski, Andrzej ^a   Rutkowski, Bolesław ^a  

^a MEDICAL UNIVERSITY OF GDANSK   (Poland)

^b MAYO CLINIC   (United States)

Author keywords

CD152; CD4; CD8; Flow cytometry; Haemodialysis; Recombinant human erythropoietin

Indexed keywords

CD4 ANTIGEN; CD8 ANTIGEN; CYTOTOXIC T LYMPHOCYTE ANTIGEN 4; FERRIC HYDROXIDE SUCROSE; INTERLEUKIN 10; INTERLEUKIN 12; INTERLEUKIN 2; INTERLEUKIN 6; LYMPHOCYTE ANTIGEN; PHYTOHEMAGGLUTININ; RECOMBINANT ERYTHROPOIETIN; TUMOR NECROSIS FACTOR ALPHA; UNCLASSIFIED DRUG; ABATACEPT; ANTIANEMIC AGENT; ANTIBODY CONJUGATE; CYTOKINE; CYTOTOXIC T-LYMPHOCYTE ANTIGEN 4; DIFFERENTIATION ANTIGEN; FERRITIN; LEUKOCYTE ANTIGEN; TRANSFERRIN;

ADULT; AGED; ANTIGEN EXPRESSION; ARTICLE; BIOASSAY; BLOOD SAMPLING; CELL CULTURE; CLINICAL ARTICLE; CONCENTRATION (PARAMETERS); CONTROLLED STUDY; DOSE RESPONSE; DRUG EFFECT; ENZYME LINKED IMMUNOSORBENT ASSAY; FLOW CYTOMETRY; FOLLOW UP; GLOMERULONEPHRITIS; HEMODIALYSIS PATIENT; HUMAN; HUMAN CELL; IMMUNE RESPONSE; IN VITRO STUDY; LONG TERM CARE; LYMPHOCYTOPENIA; PHENOTYPE; PRIORITY JOURNAL; SUPERNATANT; T LYMPHOCYTE SUBPOPULATION; TH1 CELL; ANEMIA; BLOOD; CD4 CD8 RATIO; IMMUNOLOGY; LYMPHOCYTE; LYMPHOCYTE COUNT; METABOLISM; MIDDLE AGED; RENAL REPLACEMENT THERAPY; TIME;

ANEMIA; ANTIGENS, CD; ANTIGENS, DIFFERENTIATION; CD4-CD8 RATIO; CYTOKINES; EPOETIN ALFA; FERRITINS; GLOMERULONEPHRITIS; HEMATINICS; HUMANS; IMMUNOCONJUGATES; LYMPHOCYTE COUNT; LYMPHOCYTES; MIDDLE AGED; RENAL DIALYSIS; TIME FACTORS; TRANSFERRIN;

EID: 0035992018     PISSN: 09310509     EISSN: None     Source Type: Journal    
DOI: 10.1093/ndt/17.6.1070     Document Type: Article

References (25)

1. T cell function in chronic renal failure and dialysis
2. 2-microglobulin
3. Increased incidence of tuberculosis in patients undergoing hemodialysis
4. Improved immunoglobulin production in dialysis patients treated with recombinant erythropoietin
5. Lymphocyte subsets and delayed cutaneous hypersensitivity in hemodialysis patients receiving recombinant human erythropoietin
6. Erythropoietin has amitogenic and positive chemotactic effect on endothelial cells
7. The gene for erythropoitein receptor is expressed in multipotential hemopoietic and embryonal stem cells: Evidence for differentiation stage-specific regulation
8. Recombinant human erythropoietin stimulates production of interleukin 2 by whole blood cell cultures of hemodialysis patients
9. The influence of recombinant human erythropoietin on tumor necrosis factor α and interleukin 10 production by whole blood cell cultures of hemodialysis patients
10. Recombinant human erythropoietin increases interleukin 1β production in cultured peripheral blood mononuclear cells from patients resistant to recombinant human erythropoietin therapy
11. Effect of chronic human recombinant erythropoietin therapy on antibody responses to immunisation in chronic hemodialysis patients
12. Recombinant erythropoietin reverses polymorphonuclear granulocyte dysfunction in iron-overloaded dialysis patients
13. Coexpression and functional cooperation of CTLA-4 and CD28 on activated T lymphocytes
14. The role of CD80, CD86, and CTLA4 in alloimmune responses and the induction of long-term allograft survival
15. CTLA-4 regulates tolerance induction and T cell differentiation in vivo
16. Expression and function of CTLA-4 in Th1 and Th2 cells
17. Loss of CTLA-4 leads to massive lymphoproliferation and fatal multiorgan tissue destruction, revealing a critical negative regulatory role of CTLA-4
18. Activated T cells can induce high levels of CTLA-4 expression on B cells
19. Immunosuppression in vivo by a soluble form of the CTLA-4 cell activation molecules
20. CTLA4 Ig gene transfer prolongs survival and induces donor-specific tolerance in a rat renal allograft
21. CTLA4-Ig and anti-CD40 ligand prevent renal allograft rejection in primates
22. Treatment with rHuEpo increases antibody titers after hepatitis B vaccination in dialysis patients
23. Short-term effect of erythropoietin on T-cell mitogenic proliferation in chronic renal failure patients
24. Defective expression of B7-2 (CD86) on monocytes of dialysis patients correlates to the uremia-associated immune defect
25. Expression of inducible lymphocyte co-stimulatory molecules in human renal allograft